Nazarbayev University is dedicated to excellence in research, striving to make a meaningful impact on the socio-economic development of Kazakhstan and the region. Its research spans both fundamental and applied fields, with a strong focus on STEM disciplines, life sciences, social sciences, and education — aligning with the country’s key development priorities.NU continues to strengthen its research capabilities to tackle global challenges through collaboration with government, industry, research institutions, and other key stakeholders.
Our research translates into tangible benefits for Kazakhstan and the region. We showcase success stories, highlight innovations, and demonstrate the positive impact of our work on socio-economic development.
Revolutionizing Therapy for Children with Autism:
AI-Powered Smart Insoles
We have developed an innovative AI-powered insole designed to support children with autism in improving motor coordination and sensory integration. These smart insoles use advanced sensors to monitor gait and foot pressure, providing real-time data to caregivers and therapists. This data-driven approach enhances therapy effectiveness, leading to better mobility and sensory adaptation.
With a growing demand for accessible and data-driven therapeutic tools, our solution stands at the intersection of AI, wearable technology, and healthcare. This market presents a significant investment opportunity, addressing a critical need while offering scalability in pediatric therapy, rehabilitation, and beyond. Partner with us to bring this groundbreaking technology to families and healthcare providers worldwide.
The Domestic Anticancer Drug DVC Developed by NU
Cancers, especially those associated with KRAS mutations—most commonly found in pancreatic, colorectal, and lung cancers—remain a serious medical challenge. We are developing a domestic anticancer drug to compete globally and improve survival rates for patients with aggressive cancers.
Our patented formula combines a high-dose stereoisomer of vitamin C with low-concentration arsenic, disrupting the redox balance of cancer cells and causing their death. Currently in clinical trials, the drug is exclusively licensed to Nazarbayev University, with plans for large-scale production and international expansion.
With Kazakhstan now producing the vitamin C stereoisomer, the drug is also planned to be manufactured in a powder form, bringing new hope to patients worldwide and marking an important step toward a healthier future.
Preservation and Long-Term Transport of Donor Hearts/Organs
Kazakhstani cardiac surgeons are developing a device that removes and preserves the human heart, significantly improving transplantation outcomes. The technology keeps organs viable for at least 24 hours, with future plans to include kidney preservation. Surgeons can sustain a heart for up to 29 hours and successfully perform transplants.
Unlike existing systems, this device preserves an isolated organ for a longer period while enabling full treatment, including intravascular ultrasound for evaluation and nourishment, ensuring a safer transplant process.
Find more information on nla.nu.edu.kz
